Showing results (1-10 of 168) with videos related to

Sort By:
Pageof 17
ACS Medicinal Chemistry Letters|June 20, 2020
Assembling Pharma Resources to Tackle Diseases of Underserved PopulationsDale J Kempf, Kennan C Marsh
Bioorganic & Medicinal Chemistry Letters|August 15, 2009
Synthesis and evaluation of inhibitors of cytochrome P450 3A (CYP3A) for pharmacokinetic enhancement of drugsCharles A Flentge, John T Randolph, Peggy P Huang, et al.
Bioorganic & Medicinal Chemistry Letters|October 14, 2003
Synthesis and SAR studies of potent HIV protease inhibitors containing novel dimethylphenoxyl acetates as P2 ligandsXiaoqi Chen, Dale J Kempf, Lin Li, et al.
Chemistry & Biology|October 19, 2004
An 'inside-the-box' approach to drug resistanceKent D Stewart, Dale J Kempf
Journal of Medicinal Chemistry|April 8, 2009
Water-soluble prodrugs of the human immunodeficiency virus protease inhibitors lopinavir and ritonavirDavid A DeGoey, David J Grampovnik, William J Flosi, et al.
Antiviral Chemistry & Chemotherapy|July 14, 2007
Pharmacokinetic enhancement of the hepatitis C virus protease inhibitors VX-950 and SCH 503034 by co-dosing with ritonavirDale J Kempf, Cheri Klein, Hui-Ju Chen, et al.
Pharmaceutical Research|October 23, 2004
Metabolism and disposition of the HIV-1 protease inhibitor lopinavir (ABT-378) given in combination with ritonavir in rats, dogs, and humansGondi N Kumar, Venkata K Jayanti, Marianne K Johnson, et al.
Bioorganic & Medicinal Chemistry Letters|May 7, 2013
Discovery of pyrido[2,3-d]pyrimidine-based inhibitors of HCV NS5ADavid A DeGoey, David A Betebenner, David J Grampovnik, et al.
Veterinary Journal (London, England : 1997)|June 16, 2010
Liver transcriptomic changes associated with ritonavir-induced hyperlipidemia in sensitive and resistant strains of ratsYi Yang, Annette J Dahly-Vernon, Eric A G Blomme, et al.
Pageof 17